Compare / See the difference
SAME CATEGORY?
LOOK AGAIN.
Put two signaling stories next to each other and look for the actual difference.
Signal comparison / 03
WHAT DOES THE THIRD SIGNAL CHANGE?
Tirzepatide and retatrutide make a clear two-versus-three-receptor comparison.
01
Tirzepatide
- Starting signal
- GIP + GLP-1 receptors
- Plain-language role
- Two incretin receptor targets.
- Evidence in this story
- Described in FDA prescribing information.
02
Retatrutide
- Starting signal
- GIP + GLP-1 + glucagon receptors
- Plain-language role
- A third receptor target adds a distinct research question.
- Evidence in this story
- Published randomized Phase 2 research.
What this comparison cannot tell you
Receptor count alone cannot compare efficacy or safety across different trials.
Beyond the field guide / Community
MORE QUESTIONS? TALK IT THROUGH.
Explore GLP-1 and peptide discussions, ask questions, and read shared experiences on glp1chat.
Visit glp1chat Independent forum · Opens in a new tab
GeneTune